Global Home and Alternate Site Infusion Therapy Market Research Report 2023

Home and specialty infusion is a vast arena of pharmaceutical services provided in the outpatient setting, typically in the patient’s home or an infusion suite. The majority of these medications involve administration through a needle or catheter, otherwise known as infusion, while others are administered via alternate routes of administration such as intramuscular, epidural, and self-injectable means. Infusion medications are prescribed for both acute and chronic illnesses that cannot be effectively treated with oral medications alone. Patients may shorten or avoid stays in institutions such as hospitals and nursing homes when their infusion therapy can be provided in alternate-site settings including their homes and ambulatory infusion centers.

The global Home and Alternate Site Infusion Therapy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Home and Alternate Site Infusion Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Home and Alternate Site Infusion Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Home and Alternate Site Infusion Therapy in Residential is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Home and Alternate Site Infusion Therapy include Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, McLaren, CHI Health, Accredo Health, PharMerica and Cleveland Clinic, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Home and Alternate Site Infusion Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Home and Alternate Site Infusion Therapy.

The Home and Alternate Site Infusion Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Home and Alternate Site Infusion Therapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Home and Alternate Site Infusion Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Home and Alternate Site Infusion Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Chemotherapy

1.2.3 Anti-infective Therapies

1.2.4 Immune Therapy

1.2.5 General Nursing Services

1.2.6 Others

1.3 Market by Application

1.3.1 Global Home and Alternate Site Infusion Therapy Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Residential

1.3.3 Ambulatory Infusion Centers

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Home and Alternate Site Infusion Therapy Market Perspective (2018-2029)

2.2 Home and Alternate Site Infusion Therapy Growth Trends by Region

2.2.1 Global Home and Alternate Site Infusion Therapy Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Home and Alternate Site Infusion Therapy Historic Market Size by Region (2018-2023)

2.2.3 Home and Alternate Site Infusion Therapy Forecasted Market Size by Region (2024-2029)

2.3 Home and Alternate Site Infusion Therapy Market Dynamics

2.3.1 Home and Alternate Site Infusion Therapy Industry Trends

2.3.2 Home and Alternate Site Infusion Therapy Market Drivers

2.3.3 Home and Alternate Site Infusion Therapy Market Challenges

2.3.4 Home and Alternate Site Infusion Therapy Market Restraints

3.1 Global Top Home and Alternate Site Infusion Therapy Players by Revenue

3.1.1 Global Top Home and Alternate Site Infusion Therapy Players by Revenue (2018-2023)

3.1.2 Global Home and Alternate Site Infusion Therapy Revenue Market Share by Players (2018-2023)

3.2 Global Home and Alternate Site Infusion Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Home and Alternate Site Infusion Therapy Revenue

3.4 Global Home and Alternate Site Infusion Therapy Market Concentration Ratio

3.4.1 Global Home and Alternate Site Infusion Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Home and Alternate Site Infusion Therapy Revenue in 2022

3.5 Home and Alternate Site Infusion Therapy Key Players Head office and Area Served

3.6 Key Players Home and Alternate Site Infusion Therapy Product Solution and Service

3.7 Date of Enter into Home and Alternate Site Infusion Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Home and Alternate Site Infusion Therapy Historic Market Size by Type (2018-2023)

4.2 Global Home and Alternate Site Infusion Therapy Forecasted Market Size by Type (2024-2029)

5.1 Global Home and Alternate Site Infusion Therapy Historic Market Size by Application (2018-2023)

5.2 Global Home and Alternate Site Infusion Therapy Forecasted Market Size by Application (2024-2029)

6.1 North America Home and Alternate Site Infusion Therapy Market Size (2018-2029)

6.2 North America Home and Alternate Site Infusion Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Home and Alternate Site Infusion Therapy Market Size by Country (2018-2023)

6.4 North America Home and Alternate Site Infusion Therapy Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Home and Alternate Site Infusion Therapy Market Size (2018-2029)

7.2 Europe Home and Alternate Site Infusion Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Home and Alternate Site Infusion Therapy Market Size by Country (2018-2023)

7.4 Europe Home and Alternate Site Infusion Therapy Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Home and Alternate Site Infusion Therapy Market Size (2018-2029)

8.2 Asia-Pacific Home and Alternate Site Infusion Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Home and Alternate Site Infusion Therapy Market Size by Region (2018-2023)

8.4 Asia-Pacific Home and Alternate Site Infusion Therapy Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Home and Alternate Site Infusion Therapy Market Size (2018-2029)

9.2 Latin America Home and Alternate Site Infusion Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Home and Alternate Site Infusion Therapy Market Size by Country (2018-2023)

9.4 Latin America Home and Alternate Site Infusion Therapy Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Home and Alternate Site Infusion Therapy Market Size (2018-2029)

10.2 Middle East & Africa Home and Alternate Site Infusion Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Home and Alternate Site Infusion Therapy Market Size by Country (2018-2023)

10.4 Middle East & Africa Home and Alternate Site Infusion Therapy Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Option Care Health

11.1.1 Option Care Health Company Detail

11.1.2 Option Care Health Business Overview

11.1.3 Option Care Health Home and Alternate Site Infusion Therapy Introduction

11.1.4 Option Care Health Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023)

11.1.5 Option Care Health Recent Development

11.2 Coram CVS

11.2.1 Coram CVS Company Detail

11.2.2 Coram CVS Business Overview

11.2.3 Coram CVS Home and Alternate Site Infusion Therapy Introduction

11.2.4 Coram CVS Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023)

11.2.5 Coram CVS Recent Development

11.3 UnitedHealth Group

11.3.1 UnitedHealth Group Company Detail

11.3.2 UnitedHealth Group Business Overview

11.3.3 UnitedHealth Group Home and Alternate Site Infusion Therapy Introduction

11.3.4 UnitedHealth Group Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023)

11.3.5 UnitedHealth Group Recent Development

11.4 HCA Healthcare

11.4.1 HCA Healthcare Company Detail

11.4.2 HCA Healthcare Business Overview

11.4.3 HCA Healthcare Home and Alternate Site Infusion Therapy Introduction

11.4.4 HCA Healthcare Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023)

11.4.5 HCA Healthcare Recent Development

11.5 McLaren

11.5.1 McLaren Company Detail

11.5.2 McLaren Business Overview

11.5.3 McLaren Home and Alternate Site Infusion Therapy Introduction

11.5.4 McLaren Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023)

11.5.5 McLaren Recent Development

11.6 CHI Health

11.6.1 CHI Health Company Detail

11.6.2 CHI Health Business Overview

11.6.3 CHI Health Home and Alternate Site Infusion Therapy Introduction

11.6.4 CHI Health Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023)

11.6.5 CHI Health Recent Development

11.7 Accredo Health

11.7.1 Accredo Health Company Detail

11.7.2 Accredo Health Business Overview

11.7.3 Accredo Health Home and Alternate Site Infusion Therapy Introduction

11.7.4 Accredo Health Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023)

11.7.5 Accredo Health Recent Development

11.8 PharMerica

11.8.1 PharMerica Company Detail

11.8.2 PharMerica Business Overview

11.8.3 PharMerica Home and Alternate Site Infusion Therapy Introduction

11.8.4 PharMerica Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023)

11.8.5 PharMerica Recent Development

11.9 Cleveland Clinic

11.9.1 Cleveland Clinic Company Detail

11.9.2 Cleveland Clinic Business Overview

11.9.3 Cleveland Clinic Home and Alternate Site Infusion Therapy Introduction

11.9.4 Cleveland Clinic Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023)

11.9.5 Cleveland Clinic Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Home and Alternate Site Infusion Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Chemotherapy

    Table 3. Key Players of Anti-infective Therapies

    Table 4. Key Players of Immune Therapy

    Table 5. Key Players of General Nursing Services

    Table 6. Key Players of Others

    Table 7. Global Home and Alternate Site Infusion Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Home and Alternate Site Infusion Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Home and Alternate Site Infusion Therapy Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Home and Alternate Site Infusion Therapy Market Share by Region (2018-2023)

    Table 11. Global Home and Alternate Site Infusion Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Home and Alternate Site Infusion Therapy Market Share by Region (2024-2029)

    Table 13. Home and Alternate Site Infusion Therapy Market Trends

    Table 14. Home and Alternate Site Infusion Therapy Market Drivers

    Table 15. Home and Alternate Site Infusion Therapy Market Challenges

    Table 16. Home and Alternate Site Infusion Therapy Market Restraints

    Table 17. Global Home and Alternate Site Infusion Therapy Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Home and Alternate Site Infusion Therapy Market Share by Players (2018-2023)

    Table 19. Global Top Home and Alternate Site Infusion Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Home and Alternate Site Infusion Therapy as of 2022)

    Table 20. Ranking of Global Top Home and Alternate Site Infusion Therapy Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Home and Alternate Site Infusion Therapy Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Home and Alternate Site Infusion Therapy Product Solution and Service

    Table 24. Date of Enter into Home and Alternate Site Infusion Therapy Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Home and Alternate Site Infusion Therapy Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Home and Alternate Site Infusion Therapy Revenue Market Share by Type (2018-2023)

    Table 28. Global Home and Alternate Site Infusion Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Home and Alternate Site Infusion Therapy Revenue Market Share by Type (2024-2029)

    Table 30. Global Home and Alternate Site Infusion Therapy Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Home and Alternate Site Infusion Therapy Revenue Market Share by Application (2018-2023)

    Table 32. Global Home and Alternate Site Infusion Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Home and Alternate Site Infusion Therapy Revenue Market Share by Application (2024-2029)

    Table 34. North America Home and Alternate Site Infusion Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Home and Alternate Site Infusion Therapy Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Home and Alternate Site Infusion Therapy Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Home and Alternate Site Infusion Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Home and Alternate Site Infusion Therapy Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Home and Alternate Site Infusion Therapy Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Home and Alternate Site Infusion Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Home and Alternate Site Infusion Therapy Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Home and Alternate Site Infusion Therapy Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Home and Alternate Site Infusion Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Home and Alternate Site Infusion Therapy Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Home and Alternate Site Infusion Therapy Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Home and Alternate Site Infusion Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Home and Alternate Site Infusion Therapy Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Home and Alternate Site Infusion Therapy Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Option Care Health Company Detail

    Table 50. Option Care Health Business Overview

    Table 51. Option Care Health Home and Alternate Site Infusion Therapy Product

    Table 52. Option Care Health Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023) & (US$ Million)

    Table 53. Option Care Health Recent Development

    Table 54. Coram CVS Company Detail

    Table 55. Coram CVS Business Overview

    Table 56. Coram CVS Home and Alternate Site Infusion Therapy Product

    Table 57. Coram CVS Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023) & (US$ Million)

    Table 58. Coram CVS Recent Development

    Table 59. UnitedHealth Group Company Detail

    Table 60. UnitedHealth Group Business Overview

    Table 61. UnitedHealth Group Home and Alternate Site Infusion Therapy Product

    Table 62. UnitedHealth Group Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023) & (US$ Million)

    Table 63. UnitedHealth Group Recent Development

    Table 64. HCA Healthcare Company Detail

    Table 65. HCA Healthcare Business Overview

    Table 66. HCA Healthcare Home and Alternate Site Infusion Therapy Product

    Table 67. HCA Healthcare Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023) & (US$ Million)

    Table 68. HCA Healthcare Recent Development

    Table 69. McLaren Company Detail

    Table 70. McLaren Business Overview

    Table 71. McLaren Home and Alternate Site Infusion Therapy Product

    Table 72. McLaren Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023) & (US$ Million)

    Table 73. McLaren Recent Development

    Table 74. CHI Health Company Detail

    Table 75. CHI Health Business Overview

    Table 76. CHI Health Home and Alternate Site Infusion Therapy Product

    Table 77. CHI Health Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023) & (US$ Million)

    Table 78. CHI Health Recent Development

    Table 79. Accredo Health Company Detail

    Table 80. Accredo Health Business Overview

    Table 81. Accredo Health Home and Alternate Site Infusion Therapy Product

    Table 82. Accredo Health Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023) & (US$ Million)

    Table 83. Accredo Health Recent Development

    Table 84. PharMerica Company Detail

    Table 85. PharMerica Business Overview

    Table 86. PharMerica Home and Alternate Site Infusion Therapy Product

    Table 87. PharMerica Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023) & (US$ Million)

    Table 88. PharMerica Recent Development

    Table 89. Cleveland Clinic Company Detail

    Table 90. Cleveland Clinic Business Overview

    Table 91. Cleveland Clinic Home and Alternate Site Infusion Therapy Product

    Table 92. Cleveland Clinic Revenue in Home and Alternate Site Infusion Therapy Business (2018-2023) & (US$ Million)

    Table 93. Cleveland Clinic Recent Development

    Table 94. Research Programs/Design for This Report

    Table 95. Key Data Information from Secondary Sources

    Table 96. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Home and Alternate Site Infusion Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Home and Alternate Site Infusion Therapy Market Share by Type: 2022 VS 2029

    Figure 3. Chemotherapy Features

    Figure 4. Anti-infective Therapies Features

    Figure 5. Immune Therapy Features

    Figure 6. General Nursing Services Features

    Figure 7. Others Features

    Figure 8. Global Home and Alternate Site Infusion Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Home and Alternate Site Infusion Therapy Market Share by Application: 2022 VS 2029

    Figure 10. Residential Case Studies

    Figure 11. Ambulatory Infusion Centers Case Studies

    Figure 12. Others Case Studies

    Figure 13. Home and Alternate Site Infusion Therapy Report Years Considered

    Figure 14. Global Home and Alternate Site Infusion Therapy Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Home and Alternate Site Infusion Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Home and Alternate Site Infusion Therapy Market Share by Region: 2022 VS 2029

    Figure 17. Global Home and Alternate Site Infusion Therapy Market Share by Players in 2022

    Figure 18. Global Top Home and Alternate Site Infusion Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Home and Alternate Site Infusion Therapy as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Home and Alternate Site Infusion Therapy Revenue in 2022

    Figure 20. North America Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Home and Alternate Site Infusion Therapy Market Share by Country (2018-2029)

    Figure 22. United States Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Home and Alternate Site Infusion Therapy Market Share by Country (2018-2029)

    Figure 26. Germany Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Home and Alternate Site Infusion Therapy Market Share by Region (2018-2029)

    Figure 34. China Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Home and Alternate Site Infusion Therapy Market Share by Country (2018-2029)

    Figure 42. Mexico Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Home and Alternate Site Infusion Therapy Market Share by Country (2018-2029)

    Figure 46. Turkey Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Home and Alternate Site Infusion Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Option Care Health Revenue Growth Rate in Home and Alternate Site Infusion Therapy Business (2018-2023)

    Figure 49. Coram CVS Revenue Growth Rate in Home and Alternate Site Infusion Therapy Business (2018-2023)

    Figure 50. UnitedHealth Group Revenue Growth Rate in Home and Alternate Site Infusion Therapy Business (2018-2023)

    Figure 51. HCA Healthcare Revenue Growth Rate in Home and Alternate Site Infusion Therapy Business (2018-2023)

    Figure 52. McLaren Revenue Growth Rate in Home and Alternate Site Infusion Therapy Business (2018-2023)

    Figure 53. CHI Health Revenue Growth Rate in Home and Alternate Site Infusion Therapy Business (2018-2023)

    Figure 54. Accredo Health Revenue Growth Rate in Home and Alternate Site Infusion Therapy Business (2018-2023)

    Figure 55. PharMerica Revenue Growth Rate in Home and Alternate Site Infusion Therapy Business (2018-2023)

    Figure 56. Cleveland Clinic Revenue Growth Rate in Home and Alternate Site Infusion Therapy Business (2018-2023)

    Figure 57. Bottom-up and Top-down Approaches for This Report

    Figure 58. Data Triangulation

    Figure 59. Key Executives Interviewed